Phase 2 Clinical Trial of OXE103 for Treating Concussion/Mild Traumatic Brain Injury (mTBI)

The study will examine whether with treatment the brain will heal faster and concussion symptoms improve or resolve.

You may qualify for the study if:

• You suffered a concussion (mild traumatic brain injury) and are experiencing symptoms
• Your injury occurred within the last 28 days
• You are between the ages of 18 and 60
• You are not currently pregnant or actively trying to become pregnant

To participate in the study, you must be able to meet the following study requirements:

• Attend a combination of several in-person and phone study visits
• Complete various questionnaires and testing
• Give yourself injections twice a day for two weeks (for the treatment groups).

For more information about the study, visit restisnotenough.com and email .